Guardian Capital LP Grows Position in AbbVie Inc. $ABBV

Guardian Capital LP increased its stake in AbbVie Inc. by 7.7% in Q3, now holding 82,528 shares valued at $19.11 million. This comes as AbbVie beat Q4 estimates, raised FY2026 guidance, and analysts maintain a “Moderate Buy” rating with a $253.15 target, despite significant insider selling and concerns about its high dividend payout ratio and recent debt offering.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin